Series A HealthTech & BioIntelligence Pitch Deck Benchmarks
Startup benchmarks for Series A HealthTech & BioIntelligence: Median Burn Multiple (1.2x), Gross Margin (74%), and Startup Health Score (80/100) across 1,233 real companies.
Audit Your Pitch Deck Before VCs See It
Check your burn multiple, unit economics, and capital efficiency against 1,233 real Series A HealthTech & BioIntelligence startups in 20 minutes.
Upload Pitch Deck for Free Audit →| Metric | P25 (Bottom 25%) | Median (50th) | P75 (Top 25%) | P90 (Top 10%) |
|---|---|---|---|---|
| Startup Health & Survivability Score (0-100) | 75 | 80 | 82 | 82 |
Verified statutory sample: 1,233 companies • Quorum requirement: N ≥ 25 • Updated: 2026-11-05
Frequently Asked Due Diligence Questions
What is a healthy burn multiple for a Series A HealthTech & BioIntelligence startup?
Across 1,233 verified companies, the median burn multiple is 1.2x. Startups in the top 25th percentile (most capital-efficient) operate at 0.8x or lower.
What startup health and survivability score do investors expect at Series A?
The median startup health score is 80 out of 100. Top quartile companies reach 82 or higher before entering partner meetings.
How can I audit my pitch deck before pitching venture capital investors?
Founders can run an automated 20-minute pitch deck audit on EstiloFlow Vantage to stress-test unit economics, cash burn, and cap table dilution against real-world sector standards.